Dextromethorphan hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution — RxCUI 2743624
RxNorm drug concept · Semantic clinical drug
RxCUI 2743624
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2743624
Official nameDextromethorphan hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution; dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG per 15 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
- What exactly does dextromethorphan do — will it stop my cough completely?
- It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
- This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
🕸️ Concept Web — How Dextromethorphan hydrobromide 0.667 MG/ML / doxy... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextromethorphan hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution
RxCUI 2743624 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Doxylamine
3642IN -
Dextromethorphan / doxylamine
815166MIN -
Dextromethorphan hydrobromide
102490PIN -
Doxylamine succinate
23665PIN
-
Dextromethorphan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan / doxylamine Oral Solution
379167SCDF -
Dextromethorphan hydrobromide / doxylamine succinate Oral Solution
2645976SCDFP -
Dextromethorphan / doxylamine Oral Liquid Product
1154847SCDG -
Dextromethorphan / doxylamine Oral Product
1154848SCDG -
Dextromethorphan hydrobromide / doxylamine succinate Oral Liquid Product
2663530SCDGP -
Dextromethorphan hydrobromide / doxylamine succinate Oral Product
2663586SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dextromethorphan / doxylamine Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 0.667 MG/ML
1014004SCDC -
Doxylamine succinate 0.417 MG/ML
1042674SCDC
-
Dextromethorphan hydrobromide 0.667 MG/ML
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (dextromethorphan hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.67 MG/ML Oral Solution) } Pack
GPCK · 2743625 -
Dextromethorphan hydrobromide 0.667 MG/ML
SCDC · 1014004 -
Doxylamine succinate 0.417 MG/ML
SCDC · 1042674 -
Dextromethorphan / doxylamine Oral Solution
SCDF · 379167 -
Dextromethorphan hydrobromide / doxylamine succinate Oral Solution
SCDFP · 2645976 -
Dextromethorphan / doxylamine Oral Liquid Product
SCDG · 1154847 -
Dextromethorphan / doxylamine Oral Product
SCDG · 1154848 -
Dextromethorphan hydrobromide / doxylamine succinate Oral Liquid Product
SCDGP · 2663530 -
Dextromethorphan hydrobromide / doxylamine succinate Oral Product
SCDGP · 2663586
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2743624 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 79903-0414-16 | 1 KIT in 1 PACKAGE (79903-414-16) / 1 KIT in 1 KIT * 237 m... | Childrens Cough and Congestion, Childrens Cold and Cough Day, Night | WALMART INC. | 2026-05-19 |
Observed labelers:
WALMART INC. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.